Prevalence of Migraine Disease in Electrohypersensitive Patients

2023 · Unclear · Low evidence

← Research stream

UnclearLow evidencePaper 436

Among 293 EHS patients (97% women; mean age 57 ± 12 years), migraine was diagnosed in 65% (N=191; 95% CI: 60–71%) using the extended French ID Migraine questionnaire. All 12 assessed symptoms were reported as higher intensity in migraineurs than non-migraineu…

Study snapshot

Publicationmanual · 2023

Study typecross_sectional

Reported directionUnclear

Evidence ratingLow

Abstract

Prevalence of Migraine Disease in Electrohypersensitive Patients Greco F, Garnier O, Macioce V, Picot MC. Prevalence of Migraine Disease in Electrohypersensitive Patients. Journal of Clinical Medicine. 2023; 12(12):4092. doi.org Abstract Background: The vast majority of electrohypersensitive (EHS) patients present headaches on contact with an electromagnetic source. Clinical features suggest that the headaches of these patients could be a variant of the migraine disease and could be treated as such. We aimed to assess the prevalence of migraine disease in EHS patients using a validated questionnaire. Methods: Patients with EHS defined according to WHO criteria were contacted through EHS patient support associations. They were required to answer a self-questionnaire including clinical data and the extended French version of the ID Migraine questionnaire (ef-ID Migraine) to screen for the migraine disease. Migraine prevalence and its 95% confidence interval (CI) were reported. Patients’ characteristics, symptoms (rheumatology, digestive, cognitive, respiratory, cardiac, mood, cutaneous, headache, perception, genital, tinnitus and tiredness) and impact on daily life were compared between migraineur and non-migraineur patients. Results: A total of 293 patients were included (97% women, mean age 57 ± 12 years). Migraine was diagnosed in 65% (N = 191; 95% CI: 60–71%) with the ef-ID Migraine. The migraine diagnosis was accompanied by nausea/vomiting in 50% of cases, photophobia in 69% or visual disturbances in 38%. All of the 12 symptoms assessed were of higher intensity in migraineurs than in non-migraineurs. The symptoms prevented social life in 88% of migraineurs and 75% of non-migraineurs (p < 0.01). Conclusions: Our work encourages us to consider the headaches of these patients as a possible variant of the migraine disease and, possibly, to manage them according to the current recommendations. mdpi.com

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typecross_sectional

Effect directionunclear

PopulationElectrohypersensitive (EHS) patients defined according to WHO criteria, contacted through EHS patient support associations

Sample size293

ExposureNot supplied

Evidence strengthLowConfidence: 74% · Peer reviewed: yes

Main findings

Outcomes measured

Prevalence of migraine disease (screened/diagnosed via ef-ID Migraine questionnaire)
Associated migraine features (nausea/vomiting, photophobia, visual disturbances)
Symptom intensity across 12 symptom domains
Impact on daily life/social life

Limitations

Participants were recruited via EHS patient support associations (potential selection bias)
Migraine status was assessed using a self-questionnaire screening tool (ef-ID Migraine) rather than clinical diagnosis
Electromagnetic exposure characteristics (frequency, intensity, duration, specific sources) were not specified in the abstract

View raw extracted JSON

{
  "study_type": "cross_sectional",
  "exposure": {
    "band": null,
    "source": "electromagnetic source (unspecified)",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Electrohypersensitive (EHS) patients defined according to WHO criteria, contacted through EHS patient support associations",
  "sample_size": 293,
  "outcomes": [
    "Prevalence of migraine disease (screened/diagnosed via ef-ID Migraine questionnaire)",
    "Associated migraine features (nausea/vomiting, photophobia, visual disturbances)",
    "Symptom intensity across 12 symptom domains",
    "Impact on daily life/social life"
  ],
  "main_findings": "Among 293 EHS patients (97% women; mean age 57 ± 12 years), migraine was diagnosed in 65% (N=191; 95% CI: 60–71%) using the extended French ID Migraine questionnaire. All 12 assessed symptoms were reported as higher intensity in migraineurs than non-migraineurs, and symptoms prevented social life in 88% of migraineurs vs 75% of non-migraineurs (p < 0.01).",
  "effect_direction": "unclear",
  "limitations": [
    "Participants were recruited via EHS patient support associations (potential selection bias)",
    "Migraine status was assessed using a self-questionnaire screening tool (ef-ID Migraine) rather than clinical diagnosis",
    "Electromagnetic exposure characteristics (frequency, intensity, duration, specific sources) were not specified in the abstract"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "electrohypersensitivity",
    "EHS",
    "migraine",
    "headache",
    "questionnaire",
    "ef-ID Migraine",
    "prevalence",
    "WHO criteria"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.3390/jcm12124092
PubMed: Not supplied

Read the original paper →

Related papers

← Back to the Research Library